Gastroenterology and internal medicine research institute

Edmonton T5R 1W2

1 studies enrolling now · 1 studies all time

What they study most

Crohn's Disease, Obesity or Overweight

Studies at this site

• Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight — Recruiting now